-
-
The use of aspirin for the primary prevention of cardiovascular (CV) disease remains controversial. In this publication, Bartolucci updates his 2006 meta-analysis by adding three new trials to the six previous ones.
-
The benefits of cardiac rehabilitation following myocardial infarction (MI) are well known. However, whether these benefits are also seen in ambulant community-based patients who undergo percutaneous coronary intervention (PCI) is not known.
-
Percutaneous transcatheter aortic valve implantation (TAVI) is an emerging technique for the treatment of aortic stenosis (AS). By this method, a bioprosthetic valve (bovine pericardium) attached to a stent can be deployed in the aortic valve position via a catheter delivery system inserted through either the femoral artery or via the apex of the left ventricle. This technique is available in Europe and is being considered by the FDA for release in the United States.
-
In this paper, the authors present data from the Valsartan in Acute Myocardial Infarction Trial (VALIANT) on the circumstances and outcomes of cardiac arrest after myocardial infarction (MI).
-
-
This paper presents data from the Nurses' Health Study. This is a large study that was begun in 1976 which surveyed nurses with initial ages between 30 and 55 and collected data on lifestyle and other risk factors and correlated these data with the development of cardiac disease.
-
New emphasis on optimal medical therapy in atherosclerotic cardiovascular (CV) disease has focused attention on the short-term variability of blood pressure (BP) measurements and the difficulty this poses for the diagnosis and treatment of hypertension.
-
This systematic review searched for studies using any methodology that measured outcomes in cancer patients who received energy healing techniques. Some evidence of improvements in psychosocial outcomes was found, but the methodological deficiencies in the original studies undermined confidence in their findings. The reviewers call for further research studies designed according to high-quality research standards.
-
Sleep disruption in menopause is common. one-fourth to one-half of all women will note some sleep complaint during menopause, as compared to approximately 15% in the general population.